Benade Mariet, Maskew Mhairi, Chilembo Phillip, Wa Mwansa Mwansa, Savory Theodora, Nichols Brooke, Bolton Carolyn, Mulenga Lloyd B, Sivile Suilanji, Zyambo Khozya Davie, Rosen Sydney
Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.
Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
BMJ Glob Health. 2025 Aug 11;10(8):e017930. doi: 10.1136/bmjgh-2024-017930.
The first year after HIV treatment initiation or re-initiation is the period of highest risk of a treatment interruption or disengagement, yet little is known about the timing, patterns and effects of interruptions in the early treatment period.
Using routinely collected electronic medical record data from 543 Zambian facilities from 2018 to 2023, we described patterns of engagement during the first year of HIV treatment. We defined engagement patterns for months 0-6 and months 7-12 after initiation or reinitiation as (1) continuous (attended all scheduled clinic and medication pickup visits as planned; (2) cyclical (attended ≥1 visits late >28 days but returned to and remained in care) or (3) disengaged (missed a scheduled visit by >28 days and had no evidence of return).
Our sample population comprised 159 429 adult participants (61% female, median age 33). Of the 513 322 interactions observed ≤12 months after initiation, 53% occurred as planned, 22% were late ≤28 days late, 9% were >28 days late, and 17% were scheduled but never attended. In 0-6 months after initiation, 51% clients were continuously engaged, 12% cyclically engaged and 33% disengaged. Two-thirds of disengagers (21% of cohort) did not return after the initiation visit. During months 7-12, most clients who had been continuously engaged in months 0-6 (54%) remained continuous, while 18% moved to cyclical engagement. Among cyclical engagers in months 0-6, nearly half (47%) moved to being continuously engaged by month 12. Only 34% of the study population remained engaged continuously by the end of the 12-month period.
Fewer than 60% of clients initiating antiretroviral therapy care between 2018 and 2022 at Zambian facilities remained continuously engaged at month 6 and 34% at month 12. Cyclical engagement and frequent interruptions should be accepted as the norm and models of service delivery designed to accommodate them.
开始或重新开始接受艾滋病毒治疗后的第一年是治疗中断或停止的风险最高的时期,但对于早期治疗期间中断的时间、模式和影响知之甚少。
利用2018年至2023年从赞比亚543个医疗机构常规收集的电子病历数据,我们描述了艾滋病毒治疗第一年期间的参与模式。我们将开始或重新开始治疗后第0至6个月和第7至12个月的参与模式定义为:(1) 持续参与(按计划参加所有预定的诊所就诊和药物领取);(2) 周期性参与(就诊迟到超过28天但返回并继续接受治疗)或 (3) 停止参与(错过预定就诊超过28天且无返回迹象)。
我们的样本人群包括159429名成年参与者(61%为女性,中位年龄33岁)。在开始治疗后12个月内观察到的513322次互动中,53%按计划进行,22%迟到不超过28天,9%迟到超过28天,17%已预约但从未就诊。在开始治疗后的0至6个月内,51%的客户持续参与,12%周期性参与,33%停止参与。三分之二的停止参与者(占队列的21%)在首次就诊后未返回。在第7至12个月期间,大多数在第0至6个月持续参与的客户(54%)仍保持持续参与,而18%转变为周期性参与。在第0至6个月的周期性参与者中,近一半(47%)到第12个月时转变为持续参与。到12个月期末,只有34%的研究人群保持持续参与。
2018年至2022年期间在赞比亚医疗机构开始接受抗逆转录病毒治疗的客户中,不到60%在第6个月时仍持续参与,在第12个月时为34%。应将周期性参与和频繁中断视为常态,并设计适应这些情况的服务提供模式。